Medical and Pharmaceutical University of Oklahoma boosts Cherokee Nation lung cancer screening rates with NIH grant Studies by the institution have shown that Indigenous people in the U.S. have a 73% higher cancer mortality rate than others Rowan DunneOctober 21, 2024
Medical and Pharmaceutical Bright Minds Bio soars on US$35M private placement; up 5,400% in 5 days Developing drugs for the treatment of epilepsy, depression, obesity and other conditions is the company's forte Rowan DunneOctober 18, 2024
Medical and Pharmaceutical Screenings for lung and cervical cancer are increasing in Canada Lung cancer remains the leading cause of cancer-related deaths in Canada, effecting one in 14 Canadians Joseph MortonOctober 18, 2024
Medical and Pharmaceutical Can taking Aspirin reduce your risk of getting lung cancer? Some studies have indicated that it can, along with other cancers Rowan DunneOctober 17, 2024
Medical and Pharmaceutical Novocure scoops FDA approval for electric field lung cancer treatment device The Swiss oncology company's stock rose by over 33% as a result Rowan DunneOctober 16, 2024
Medical and Pharmaceutical Wave Life Sciences brings big biotech breakthrough with RNA editing therapy RNA editing involves modifying RNA to correct or alter protein production in the body Joseph MortonOctober 16, 2024
Medical and Pharmaceutical American football player passes away at 23 from rare lung cancer Tylee Craft was diagnosed with stage 4 large cell neuroendocrine carcinoma in 2022 Rowan DunneOctober 15, 2024
Medical and Pharmaceutical Alpha Tau treats first lung cancer patient with radiation therapy in Jerusalem The Israeli company has used its proprietary Alpha DaRT treatment for other cancers but not lung Rowan DunneOctober 10, 2024
Medical and Pharmaceutical bioAffinity Technologies makes phlegm lung cancer test widely available to Veterans The University of California says 15 veterans die from lung cancer around the world every day Rowan DunneOctober 9, 2024
Medical and Pharmaceutical Scholar Rock stock skyrockets on successful phase 3 trial results The SAPPHIRE study demonstrated statistically significant and clinically meaningful improvements Joseph MortonOctober 7, 2024